131 related articles for article (PubMed ID: 1854886)
1. Cyclosporin for hypereosinophilic syndrome.
Zabel P; Schlaak M
Ann Hematol; 1991 Jun; 62(6):230-1. PubMed ID: 1854886
[TBL] [Abstract][Full Text] [Related]
2. T lymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome.
Raghavachar A; Fleischer S; Frickhofen N; Heimpel H; Fleischer B
J Immunol; 1987 Dec; 139(11):3753-8. PubMed ID: 3500229
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Biological Markers in Hypereosinophilic Syndromes.
Khoury P; Makiya M; Klion AD
Front Med (Lausanne); 2017; 4():240. PubMed ID: 29312946
[TBL] [Abstract][Full Text] [Related]
4. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.
Lee CH; Mamelak AJ; Vonderheid EC
Int J Dermatol; 2007 Nov; 46(11):1198-204. PubMed ID: 17988344
[TBL] [Abstract][Full Text] [Related]
5. T cell lymphoid aggregates in bone marrow in idiopathic hypereosinophilic syndrome.
Metz J; McGrath KM; Savoia HF; Begley CG; Chetty R
J Clin Pathol; 1993 Oct; 46(10):955-8. PubMed ID: 8192747
[TBL] [Abstract][Full Text] [Related]
6. Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia.
Zimmermann N; Wikenheiser-Brokamp KA
Ann Allergy Asthma Immunol; 2018 Aug; 121(2):179-185. PubMed ID: 29803709
[TBL] [Abstract][Full Text] [Related]
7. World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2012 Sep; 87(9):903-14. PubMed ID: 22926771
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system involvement of hypereosinophilic syndrome: a report of 10 cases and a literature review.
Lee D; Ahn TB
J Neurol Sci; 2014 Dec; 347(1-2):281-7. PubMed ID: 25455301
[TBL] [Abstract][Full Text] [Related]
9. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2011 Aug; 86(8):677-88. PubMed ID: 21761433
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.
Schrezenmeier H; Thomé SD; Tewald F; Fleischer B; Raghavachar A
Exp Hematol; 1993 Feb; 21(2):358-65. PubMed ID: 8425573
[TBL] [Abstract][Full Text] [Related]
11. Response of Complex Undefined Hypereosinophilic Syndrome to Treatment with Imatinib.
Yılmaz İ; Kaynar L; Tutar N; Pala Ç; Canöz Ö; Yıldırım A; Büyükoğlan H; Gülmez İ
Turk Thorac J; 2016 Jul; 17(3):118-121. PubMed ID: 29404138
[TBL] [Abstract][Full Text] [Related]
12. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
13. Aquagenic pruritus associated with the idiopathic hypereosinophilic syndrome.
Newton JA; Singh AK; Greaves MW; Spry CJ
Br J Dermatol; 1990 Jan; 122(1):103-6. PubMed ID: 2297496
[TBL] [Abstract][Full Text] [Related]
14. Cardiac involvement mimicking acute coronary syndrome in idiopathic hypereosinophilic syndrome.
Fredy FC; Iskandar WJ; Yung Jih FK
Acta Med Indones; 2013 Oct; 45(4):302-5. PubMed ID: 24448335
[TBL] [Abstract][Full Text] [Related]
15. Co-occurrence of Idiopathic Hypereosinophilic Syndrome in End-Stage Renal Disease Patients Undergoing Maintenance Hemodialysis.
Elbahoty M; Elnaggar S; Soror N; Elkeraie A; Youssef A
Cureus; 2024 Feb; 16(2):e53758. PubMed ID: 38465088
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilic pleural effusion: a rare manifestation of hypereosinophilic syndrome.
Okafor NC; Oso AA; Oranu AC; Wolff SM; Murray JJ
Case Rep Med; 2009; 2009():635309. PubMed ID: 20111739
[TBL] [Abstract][Full Text] [Related]
17. Effective therapy for a severe case of the idiopathic hypereosinophilic syndrome.
Marshall GM; White L
Am J Pediatr Hematol Oncol; 1989; 11(2):178-83. PubMed ID: 2665548
[TBL] [Abstract][Full Text] [Related]
18. Neurological manifestations of the hypereosinophilic syndrome (HES).
Prick JJ; Gabreëls-Festen AA; Korten JJ; van der Wiel TW
Clin Neurol Neurosurg; 1988; 90(3):269-73. PubMed ID: 3197357
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of human eosinophil glucocorticoid receptor expression in hypereosinophilic patients: absence of detectable receptor correlates with resistance to corticotherapy.
Prin L; Lefebvre P; Gruart V; Capron M; Storme L; Formstecher P; Loiseau S; Capron A
Clin Exp Immunol; 1989 Dec; 78(3):383-9. PubMed ID: 2612051
[TBL] [Abstract][Full Text] [Related]
20. Focal eosinophilic myositis.
Kobayashi Y; Fujimoto T; Shiiki H; Kitaoka K; Murata K; Dohi K
Clin Rheumatol; 2001; 20(5):369-71. PubMed ID: 11642521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
